Rubella vaccination and anti-D immunoglobulin administration in the puerperium.
The serum conversion rates and post-vaccination rubella haemagglutination inhibiting antibody titres of a group of women given both anti-D immunoglobulin and rubella vaccine in the puerperium have been compared with those of a similar group of patients who were given vaccine but no immunoglobulin. The serological response to rubella vaccination in susceptible women was satisfactory even when anti-D immunoglobulin was given shortly before vaccination.
D000906:Antibodies / Q000032:analysis; D005260:Female; D006801:Humans; D007109:Immunity; D007158:Immunologic Techniques; D049590:Postpartum Period; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D012411:Rubella Vaccine / Q000494:pharmacology*
D000906:Antibodies; D012204:Rh-Hr Blood-Group System; D012411:Rubella Vaccine